drugset / Trial / NCT07610369
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Phase 2
Recruiting
40 enrolled
Yale University
Michael J. Fox Foundation for Parkinson's Research · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
Timeline
- Start
- 2026-07
- Primary completion
- 2030-07
- Completion
- 2030-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | — | Oral |